经尿道等离子双极电切术治疗前列腺增生

Transurethral Plasmakinetic Vaporization of Prostate for Treatment of BPH Patients

目的:探讨前列腺增生症(BPH)经尿道双极等离子电切术治疗效果和安全性。方法:采用经尿道等离子前列腺电切术(PKRP)治疗BPH158例,随访3～24个月。结果:前列腺重量平均75.8g,手术时间(45±20)min。术后留置尿管(2.5±2.0)d,术后住院时间(3.0±2.0)d。最大尿流率(Qmax)由术前的(5.2±1.8)ml/s上升至术后3个月的(14.8±3.2)ml/s(P<0.01),前列腺症状评分(I-PSS)术前为(28.3±1.5)分,术后3个月降至(4.9±1.1)分(P<0.01)。结论:经尿道双极等离子前列腺电切术手术效果良好,并发症少,手术安全。

Objective: In order to evaluate the validity and safety of transurethral plasmakinetic resection of benigh prostatic hyperplasia(BPH). Method:158 cases of BPH were treated by Transurethral plasmakinetic resection of prostate(PKRP) and had been followed up at 3～24 months. Result: The mean weight of the prostate was 75.8g,The operative time was (45±20)min. The catheterization time was (2.5±2.0) days and the postoperative hospital stay was (3.0±2.0) days. Peak urine flow increased from (5.2±1.8)ml/s to (14.8±3.2)ml/s (P<0.01)and I-PSS decreased from (28.3±1.5) to (4.9±1.1) (P<0.01) at 3 months postoperatively.Conclusion: Transurethral plasmakinetic resection of prostate is effective with less complications;It is recommended for the treatment of symptomatic BPH.